| Symbol | AMRN |
|---|---|
| Name | AMARIN CORP PLC\UK |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | SPACES SOUTH DOCKLANDS, BLOCK C, DUBLIN 2, None None |
| Telephone | 353 1 6699 020 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000897448 |
| Description | None |
Amarin Highlights New REDUCE-IT® and Mechanistic Data Presented at European Society of Cardiology (ESC) Congress 2026
Read moreNew REDUCE-IT® Legacy Analysis Presented at European Society of Cardiology (ESC) Congress 2026 Suggests Persistent Cardiovascular Benefit Following Icosapent Ethyl Treatment Cessation in Adherent Patients
Read moreNew Form SCHEDULE 13D/A - AMARIN CORP PLC\UK <b>Filed:</b> 2026-08-27 <b>AccNo:</b> 0000899140-26-000972 <b>Size:</b> 1 MB
Read moreNew Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026
Read moreFishman Peter L. 🟡 adjusted position in 471 shares (1 derivative) of AMARIN CORP PLC\UK (AMRN) at $14.26 Transaction Date: Aug 01, 2026 | Filing ID: 330669
Read more(30% Negative) AMARIN CORP PLC\UK (AMRN) Reports Q3 2026 Financial Results
Read moreAmarin Reports 2026 Second Quarter Financial Results Demonstrating Early Success of Fully Partnered International Commercial Strategy and Continued Leading U.S. Market Presence
Read moreFishman Peter L. 🟡 adjusted position in 3.7K shares (1 derivative) of AMARIN CORP PLC\UK (AMRN) at $15.94 Transaction Date: Jul 01, 2026 | Filing ID: 304914
Read moreKeenan David Paul 🟡 adjusted position in 5.5K shares (1 derivative) of AMARIN CORP PLC\UK (AMRN) at $15.94 Transaction Date: Jul 01, 2026 | Filing ID: 304912
Read moreKetchum Steven B 🟡 adjusted position in 5.5K shares (1 derivative) of AMARIN CORP PLC\UK (AMRN) at $15.94 Transaction Date: Jul 01, 2026 | Filing ID: 304911
Read more